ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells.

Hu, Bing*; An, Hong-Mei; Yan, Xia; Zheng, Jia-Lu; Huang, Xiao-Wei; Li, Miao
BMC Complement Altern Med2019-3-15DOI: 10.1186/s12906-019-2477-9
7阅读
引用收藏
分享

摘要

BACKGROUND: Epithelial-mesenchymal transition (EMT) is a vital process in cancer progression and metastasis. Yanggan Jiedu Sanjie (YGJDSJ) is Traditional Chinese Medicine formulation for liver cancer treatment. In the present study, we evaluated the effects of YGJDSJ on TGF-β1-induced EMT in hepatocellular carcinoma Bel-7402 cells. METHODS: Bel-7402 cells were treated with TGF-β1 and YGJDSJ. EMT was identified by morphological changes and expression of marker proteins. Cell morphology was observed under a microscope. Protein expression and phosphorylation was detected by western blotting. Cell migration was measured by the scratch assay. Cell adhesion and invasion was detected by a commercial kit. RESULTS: YGJDSJ reversed TGF-β1-induced morphological changes, as well as the expression of the EMT markers E-cadherin and N-cadherin in Bel-7402 cells. YGJDSJ also inhibited TGF-β1 up-regulated Smad3 phosphorylation and Snail expression in Bel-7402 cells. Moreover, YGJDSJ inhibited TGF-β1-induced cell adhesion, migration and invasion in Bel-7402 cells. CONCLUSIONS: YGJDSJ inhibited TGF-β1-induced EMT and mediated metastatic potential of Bel-7402 cells, which may be related to down-regulation of Smad3 phosphorylation and Snail expression. The present study provides a new basis for application of this herbal formula for prevention of liver cancer metastasis.

学科与关键词

关键词
Chinese herbal medicineEpithelial-mesenchymal transitionHepatocellular carcinomaMetastasis
相关
加载中…
  • Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma
    Sun, Jialing; Chen, Weicong; Wen, Bin; Zhang, Mingjia; Sun, Haitao; Yang, Xuemei; Zhao, Wenting; La, Lei; An, Haiyan; Pang, Jie; Gao, Lei*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 610158.被引 8
  • JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells
    Liu, Li-Hua; Fang, Chong-Kai; Ge, Fu-Cheng; Wang, Ji-Nan; Zhang, Xiu-Bing; Luo, Rui; Zhang, Ying; Feng, Kun-Liang; Qiu, Zhen-Wen*; Zhong, Chong*Journal of Oncology, 2022, 2022: 7823433.被引 6
  • Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling
    Xie, Chun-Feng; Feng, Kun-Liang; Wang, Ji-Nan; Luo, Rui; Fang, Chong-Kai; Zhang, Ying; Shen, Chuang-Peng*; Zhong, Chong*Journal of Ethnopharmacology, 2022, 294: 115360.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Complement Altern Med
发表日期
2019-03-15
卷期
第 19 卷, 第 1 期
页码
67
DOI
10.1186/s12906-019-2477-9
成果收录
PUBMED

作者

  • H

    Hu, Bing (通讯) (第一作者)

  • A

    An, Hong-Mei

查看全部 6 位作者收起作者
  • Y

    Yan, Xia

  • Z

    Zheng, Jia-Lu

  • H

    Huang, Xiao-Wei

  • L

    Li, Miao

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417